Susan Rodriguez - 13 May 2025 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role: Chief Operating Officer
Signature: /s/ Jerad G. Seurer, as Attorney-in-Fact
Issuer symbol: AVDL
Transactions as of: 13 May 2025
Net transactions value: $0
Form type: 4
Filing time: 13 May 2025, 18:01:12 UTC
Previous filing: 04 Feb 2025
Next filing: 03 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rodriguez Susan	Chief Operating Officer	C/O AVADEL PHARMACEUTICALS PLC, 10 EARLSFORT TERRACE, DUBLIN 2, IRELAND	/s/ Jerad G. Seurer, as Attorney-in-Fact	13 May 2025	0001812511

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVDL	Stock Option (Right to Buy)	Award	$0	+300,000		$0.000000	300,000	13 May 2025	Ordinary Shares	300,000	$9.59	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options become exercisable in four equal annual installments on each of the first four anniversaries following the 05/13/2025 grant date, subject to the Reporting Person's continued service at each such vesting date.